## Abstract For Abstract see ChemInform Abstract in Full Text.
Association of the Abl tyrosine kinase with the Trk nerve growth factor receptor
✍ Scribed by Hiroko Yano; Feng Cong; Raymond B. Birge; Stephen P. Goff; Moses V. Chao
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 146 KB
- Volume
- 59
- Category
- Article
- ISSN
- 0360-4012
No coin nor oath required. For personal study only.
✦ Synopsis
Nerve growth factor (NGF) initiates the majority of its biological effects by promoting the dimerization and activation of the tyrosine kinase receptor TrkA. In addition to rapid increases in the phosphorylation of phosphatidylinositol 3Јkinase (PI 3-kinase) and phospholipase C-␥ and increased ras activity, phosphorylation of c-Crk and paxillin proteins has been observed upon TrkA activation. The c-Abl tyrosine kinase is involved in the control of the axonal cytoskeleton and is known to interact with c-Crk proteins.
Here we have tested the possibility that TrkA receptors might form an association with the c-Abl protein. After transfection in 293T cells, TrkA and c-Abl kinases could be coimmunoprecipitated. This interaction did not require TrkA receptors to be autophosphorylated. Mapping analysis indicated that the region of c-Abl association was confined to the juxtamembrane region of TrkA. The interaction of c-Abl with TrkA was also observed in differentiated pheochromocytoma PC12 cells. These results suggest that c-Abl may be recruited to the NGF receptor complex and be involved in regulating specific phosphorylation events that occur during neuronal differentiation.
📜 SIMILAR VOLUMES
## Abstract The cyclic‐AMP‐dependent protein kinase A (PKA) regulates processes such as cell proliferation and migration following activation of growth factor receptor tyrosine kinases (RTKs), yet the signaling mechanisms that link PKA with growth factor receptors remain largely undefined. Here we
Tumor necrosis factor-a (TNF-a) can modulate the signalling capacity of tyrosine kinase receptors; in particular, TNF-a has been shown to mediate the insulin resistance associated with animal models of obesity and noninsulin-dependent diabetes mellitus. In order to determine whether the effects of T
We have synthesized N-(3-chloro-4-fluorophenyl)-7-[ 11 C]methoxy-6- [3-(morpholin-4yl)propoxy]quinazolin-4-amine, [ 11 C]gefitinib ([ 11 C]Iressa), a high affinity (IC 50 = 2 nM) inhibitor of the epidermal growth factor receptor tyrosine kinase (EGFR-TK), in solution and in a semi-automated stainles
## Abstract 5‐(4‐Methyl‐piperazin‐1‐yl)‐pent‐2‐ynoic acid [4‐(3‐chloro‐4‐fluoro‐phenylamino)‐pyrido[3,4‐d]pyrimidin‐6‐yl]‐amide, PD0205520, was under investigation as a potential inhibitor of the tyrosine kinase (TK) activity of the epidermal growth factor receptor (EGFR) for cancer treatment. Both